Abstract
Concentrations of plasma arginine vasopressin (AVP) were studied in patients receiving chemotherapy. Of the 18 patients studied, nine experienced nausea and vomiting and the remaining nine were nonvomiters who suffered at worst mild nausea. Plasma AVP in the non-vomiting group remained within the normal range (0.5-1.5 pmol 1(-1] throughout the sampling period. However, patients who vomited showed (with one exception) substantial rises in AVP ranging from 4 to 129-fold. Plasma AVP concentrations were outside the normal range in vomiters and were higher than in non-vomiting patients at 3 h (P less than 0.05) and 5h (P less than 0.01) after chemotherapy. One patient was sampled during consecutive treatment courses, once as a vomiter and once as a non-vomiter; results demonstrated a 16-fold rise in AVP as a vomiter and no rise as a non-vomiter. Significant changes in plasma AVP levels were also observed in patients who suffered moderate or severe nausea compared to those who had mild or no nausea (P less than 0.05). Plasma AVP may prove to be a good objective marker for nausea in future anti-emetic trials.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Carmichael J., Cantwell B. M., Edwards C. M., Rapeport W. G., Harris A. L. The serotonin type 3 receptor antagonist BRL 43694 and nausea and vomiting induced by cisplatin. BMJ. 1988 Jul 9;297(6641):110–111. doi: 10.1136/bmj.297.6641.110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Carpenter D. O., Briggs D. B., Strominger N. Behavioral and electrophysiological studies of peptide-induced emesis in dogs. Fed Proc. 1984 Dec;43(15):2952–2954. [PubMed] [Google Scholar]
- Fisher R. D., Rentschler R. E., Nelson J. C., Godfrey T. E., Wilbur D. W. Elevation of plasma antidiuretic hormones (ADH) associated with chemotherapy-induced emesis in man. Cancer Treat Rep. 1982 Jan;66(1):25–29. [PubMed] [Google Scholar]
- Hargreaves K. M., Schmidt E. A., Mueller G. P., Dionne R. A. Dexamethasone alters plasma levels of beta-endorphin and postoperative pain. Clin Pharmacol Ther. 1987 Dec;42(6):601–607. doi: 10.1038/clpt.1987.206. [DOI] [PubMed] [Google Scholar]
- Harris A. L. Cytotoxic-therapy-induced vomiting is mediated via enkephalin pathways. Lancet. 1982 Mar 27;1(8274):714–716. doi: 10.1016/s0140-6736(82)92625-3. [DOI] [PubMed] [Google Scholar]
- Norbiato G., Bevilacqua M., Chebat E., Bertora P., Cavaiani P., Baruto C., Fumagalli S., Raggi U. Metoclopramide increases vasopressin secretion. J Clin Endocrinol Metab. 1986 Sep;63(3):747–750. doi: 10.1210/jcem-63-3-747. [DOI] [PubMed] [Google Scholar]
- Nussey S. S., Hawthorn J., Page S. R., Ang V. T., Jenkins J. S. Responses of plasma oxytocin and arginine vasopressin to nausea induced by apomorphine and ipecacuanha. Clin Endocrinol (Oxf) 1988 Mar;28(3):297–304. doi: 10.1111/j.1365-2265.1988.tb01216.x. [DOI] [PubMed] [Google Scholar]
- Robertson G. L. The regulation of vasopressin function in health and disease. Recent Prog Horm Res. 1976;33:333–385. doi: 10.1016/b978-0-12-571133-3.50015-5. [DOI] [PubMed] [Google Scholar]
- Rooke P., Baylis P. H. A new sensitive radioimmunoassay for plasma arginine vasopressin. J Immunoassay. 1982;3(2):115–131. doi: 10.1080/15321818208056990. [DOI] [PubMed] [Google Scholar]
- Thomford N. R., Sirinek K. R. Intravenous vasopressin in patients with portal hypertension: advantages of continuous infusion. J Surg Res. 1975 Feb;18(2):113–117. doi: 10.1016/0022-4804(75)90006-2. [DOI] [PubMed] [Google Scholar]
- Weitzman R. E., Fisher D. A., Minick S., Ling N., Guillemin R. beta-Endorphin secretion of arginine vasopressin in vivo. Endocrinology. 1977 Nov;101(5):1643–1646. doi: 10.1210/endo-101-5-1643. [DOI] [PubMed] [Google Scholar]
- Williams T. D., Da Costa D., Mathias C. J., Bannister R., Lightman S. L. Pressor effect of arginine vasopressin in progressive autonomic failure. Clin Sci (Lond) 1986 Aug;71(2):173–178. doi: 10.1042/cs0710173. [DOI] [PubMed] [Google Scholar]